Cannabis in Gastrointestinal Disorders

Explores effects on the gastrointestinal system, including inflammatory bowel disease, irritable bowel syndrome, nausea, and appetite modulation. Mechanistic insights into gut-brain interactions and microbiome modulation are discussed. Clinical evidence, innovative delivery strategies, and safety considerations are highlighted. Personalized treatment approaches for GI disorders are presented. Future research directions for gastrointestinal-focused therapies are proposed.

    Related Conference of Cannabis in Gastrointestinal Disorders

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland

    Cannabis in Gastrointestinal Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in